SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : King Pharmaceuticals, Inc. (Nasdaq:KG)(Was KING)
KG 21.27-9.6%Oct 30 3:56 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Randi who wrote ()8/31/1999 10:07:00 PM
From: Walkingshadow  Read Replies (1) of 61
 
Altace and HOPE trial:

Report on Reuters today about HOPE trial results, in which the PI (Dr. John Kennedy) stated:

"At the time of discharge from hospital we would anticipate now that they [patients admitted for a heart attack or stroke] would in future be prescribed ramipril on the basis of evidence accrued from this study."

I don't have numbers at the tips of my fingers, but this is a very large market, I'm guessing about 1.5 million patients annually in the U.S. And this, of perhaps even greater significance:

"Hoechst Marion Roussel said it would apply for a licence for the drug to be used as a preventive measure based on the results of the study."

The first statement refers to secondary prevention (prevention of a second event in those who have already suffered an event) as an indication. The second statement, however, refers to a vastly larger market---those who have never had an event, but who have risk factors such as high blood pressure, high cholesterol, family history, age, etc. (primary prevention).

I had been considering selling KING at this point, but in light of the above, that may not be the wisest course.......

Regards,

Walkingshadow
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News